Position in BHC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,270,785
+$650,809 QoQ
Shares Held
866,285
+29.2% QoQ
Ownership
0.232%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#34
of 220 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. BHC ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
This page
|
866,285 | $4,270,785 |
All Filings in BHC
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,270,785 | 866,285 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,619,976 | 670,366 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,401,614 | 489,441 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,815,766 | 436,553 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,958,789 | 744,563 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $5,234,100 | 808,980 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,045,410 | 501,912 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,916,155 | 234,823 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,726,998 | 247,776 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $748,270 | 70,525 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $442,888 | 55,223 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $741,131 | 90,162 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $701,504 | 87,688 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $609,176 | 75,207 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $529,812 | 84,365 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $536,889 | 77,923 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $763,334 | 91,308 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,910,723 | 258,675 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,010,214 | 145,245 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,388,610 | 85,767 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,380,508 | 115,297 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $3,803,277 | 119,826 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,639,331 | 78,814 | Shares | Sole | 2021-02-12 | |
| 2020-03-31 | $1,755,483 | 113,257 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||